ZOOMMED INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 CAD | -.--% |
|
-.--% | -.--% |
| 22/01 | ZoomMed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023 | CI |
| 2023 | ZoomMed Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023 | CI |
| Sales 2022 | 11.15K 8.17K 681K | Sales 2023 | 13.01K 9.53K 795K | Capitalization | 2.03M 1.49M 124M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -733K -61.1M | Net income 2023 | - 0 0 | EV / Sales 2022 | 168 x |
| Net cash position 2022 | 161K 118K 9.81M | Net Debt 2023 | 393K 288K 23.99M | EV / Sales 2023 | 186 x |
| P/E ratio 2022 |
-1.66
x | P/E ratio 2023 |
11.6
x | Employees | 40 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.02% |
More Fundamentals
* Assessed data
More news
More news
10 years
0.01
0.06
| Managers | Title | Age | Since |
|---|---|---|---|
Yves Marmet
CEO | Chief Executive Officer | - | 01/05/01 |
| Director of Finance/CFO | - | 01/05/01 | |
Sébastie Ouellet
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Powell
BRD | Director/Board Member | - | 01/05/01 |
André Marmet
PRN | Corporate Officer/Principal | - | 01/05/01 |
| Director of Finance/CFO | - | 01/05/01 |
ZoomMed Inc. is a Canada-based company, which builds and operates ZoomMedâs Communication Network, a clinical interoperable information exchange network between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers.
Calendar
27/09/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 1.65M | |
| +4.36% | 32.47B | |
| +16.32% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.17B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M |
- Stock Market
- Equities
- ZMD.H Stock
